SMART FOR LIFE INC (SMFL)

US83204U6082 - Common Stock

0.78  -0.26 (-25%)

After market: 0.3977 -0.38 (-49.01%)

Fundamental Rating

1

SMFL gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. SMFL has a bad profitability rating. Also its financial health evaluation is rather negative. SMFL is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SMFL has reported negative net income.
SMFL had a negative operating cash flow in the past year.

1.2 Ratios

SMFL's Return On Assets of -81.91% is on the low side compared to the rest of the industry. SMFL is outperformed by 89.19% of its industry peers.
SMFL has a Return On Equity of -2197.35%. This is amonst the worse of the industry: SMFL underperforms 91.89% of its industry peers.
Industry RankSector Rank
ROA -81.91%
ROE -2197.35%
ROIC N/A
ROA(3y)-102.86%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SMFL has a worse Gross Margin (14.20%) than 83.78% of its industry peers.
In the last couple of years the Gross Margin of SMFL has grown nicely.
SMFL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y138.26%
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

SMFL does not have a ROIC to compare to the WACC, probably because it is not profitable.
SMFL has more shares outstanding than it did 1 year ago.
The debt/assets ratio for SMFL has been reduced compared to a year ago.

2.2 Solvency

SMFL has an Altman-Z score of -5.13. This is a bad value and indicates that SMFL is not financially healthy and even has some risk of bankruptcy.
SMFL's Altman-Z score of -5.13 is on the low side compared to the rest of the industry. SMFL is outperformed by 94.59% of its industry peers.
SMFL has a Debt/Equity ratio of 8.93. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 8.93, SMFL is doing worse than 91.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 8.93
Debt/FCF N/A
Altman-Z -5.13
ROIC/WACCN/A
WACC15.68%

2.3 Liquidity

SMFL has a Current Ratio of 0.18. This is a bad value and indicates that SMFL is not financially healthy enough and could expect problems in meeting its short term obligations.
SMFL has a worse Current ratio (0.18) than 94.59% of its industry peers.
A Quick Ratio of 0.04 indicates that SMFL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.04, SMFL is doing worse than 97.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.04

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.52% over the past year.
Looking at the last year, SMFL shows a very negative growth in Revenue. The Revenue has decreased by -39.39% in the last year.
Measured over the past years, SMFL shows a very strong growth in Revenue. The Revenue has been growing by 95.85% on average per year.
EPS 1Y (TTM)55.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75000%
Revenue 1Y (TTM)-39.39%
Revenue growth 3Y95.85%
Revenue growth 5YN/A
Sales Q2Q%-48.66%

3.2 Future

The Earnings Per Share is expected to grow by 25.82% on average over the next years. This is a very strong growth
SMFL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.83% yearly.
EPS Next Y98.51%
EPS Next 2Y41.42%
EPS Next 3Y25.82%
EPS Next 5YN/A
Revenue Next Year-35.28%
Revenue Next 2Y-15.63%
Revenue Next 3Y-7.83%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SMFL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SMFL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

SMFL's earnings are expected to grow with 25.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y25.82%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SMFL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SMART FOR LIFE INC

NASDAQ:SMFL (9/18/2024, 8:00:03 PM)

After market: 0.3977 -0.38 (-49.01%)

0.78

-0.26 (-25%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-20 2023-11-20/amc
Earnings (Next)N/A N/A
Inst Owners30.82%
Inst Owner Change-58.38%
Ins Owners10044.86%
Ins Owner Change-0.19%
Market Cap85.80K
Analysts43.33
Price Target8.16 (946.15%)
Short Float %0.53%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.64%
Min EPS beat(2)23.35%
Max EPS beat(2)35.92%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.76%
Min Revenue beat(2)-25.39%
Max Revenue beat(2)-10.12%
Revenue beat(4)0
Avg Revenue beat(4)-32.72%
Min Revenue beat(4)-73.72%
Max Revenue beat(4)-10.12%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.09
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-603.43
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-63.16
FCFYN/A
OCF(TTM)-63.2
OCFYN/A
SpS100.98
BVpS8.65
TBVpS-174.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -81.91%
ROE -2197.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.2%
FCFM N/A
ROA(3y)-102.86%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y138.26%
GM growth 5YN/A
F-Score2
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 8.93
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.17%
Cap/Sales 0.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.04
Altman-Z -5.13
F-Score2
WACC15.68%
ROIC/WACCN/A
Cap/Depr(3y)60.78%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.83%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75000%
EPS Next Y98.51%
EPS Next 2Y41.42%
EPS Next 3Y25.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-39.39%
Revenue growth 3Y95.85%
Revenue growth 5YN/A
Sales Q2Q%-48.66%
Revenue Next Year-35.28%
Revenue Next 2Y-15.63%
Revenue Next 3Y-7.83%
Revenue Next 5YN/A
EBIT growth 1Y-67.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-11.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.18%
OCF growth 3YN/A
OCF growth 5YN/A